Literature DB >> 565310

Effect of secretin on basal- and glucose-stimulated insulin secretion in man.

J Fahrenkrug, O B Schaffalitzky de Muckadell, C Kühl.   

Abstract

Plasma immunoreactive secretin and insulin concentrations were measured in fasting normal humans after intraduodenal infusions of hydrochloric acid, isotonic or hypertonic glucose. The effect of intraduodenal acidification or intravenous bolus injections of secretin on plasma insulin concentrations during infusions of glucose was also examined. The intraduodenal glucose load did not cause an increase in plasma secretin concentrations. Secretin concentrations rose after acid both in the fasting state and during infusions of glucose. A concomitant rise in insulin levels was however only observed during infusions of glucose. Intravenous injection of secretin in a dose which mimicked the response to intraduodenal acidification was without effect on the glucose-stimulated insulin release, while a 30 times higher dose caused a highly significant augmentation of the insulin release. The insulin response pattern to this high dose of secretin differed completely from that observed after intraduodenal infusion of acid. It is concluded and confirmed that the stimulating effect of secretin on insulin secretion is pharmacological and that secretin plays no significant role in the entero-insular axis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 565310     DOI: 10.1007/bf01219421

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Preparation of 125I-labeled synthetic porcine secretin for radioimmunoassay.

Authors:  O B de Muckadell; J Fahrenkrug
Journal:  Scand J Clin Lab Invest       Date:  1976-11       Impact factor: 1.713

2.  Failure of endogenous stimulation of secretin and pancreozymin release to influence serum-insulin.

Authors:  R J Mahler; H Weisberg
Journal:  Lancet       Date:  1968-03-02       Impact factor: 79.321

3.  Measurement of endogenous release of cholecystokinin by radioimmunoassay.

Authors:  D D Reeder; H D Becker; N J Smith; P L Rayford; J C Thompson
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

4.  The effect of secretin on pancreatic glucoregulatory hormones in man.

Authors:  R J Dudl; R L Lerner; J W Ensinck; R H Williams
Journal:  Horm Metab Res       Date:  1973-07       Impact factor: 2.936

5.  Secretin and insulin: response to intraduodenal acid.

Authors:  F A O'Connor; K D Buchanan; J J Connon; M Shahidullah
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

6.  Glucose metabolism during and after pregnancy in normal and gestational diabetic women. 1. Influence of normal pregnancy on serum glucose and insulin concentration during basal fasting conditions and after a challenge with glucose.

Authors:  C Kühl
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

7.  The gastrointestinal stimulus to insulin release. I. Secretin.

Authors:  D J Chisholm; J D Young; L Lazarus
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

8.  The gastrointestinal stimulus to insulin release. II. A dual action of secretin.

Authors:  E W Kraegen; D J Chisholm; J D Young; L Lazarus
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

9.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

10.  Secretion of glucagon from the isolated, perfused canine pancreas.

Authors:  J Iversen
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

View more
  12 in total

Review 1.  Secretin: Should we revisit its metabolic outcomes?

Authors:  D H St-Pierre; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

Review 2.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

3.  Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas.

Authors:  M Otsuki; Y Okabayashi; T Nakamura; M Fujii; T Oka; S Tani; S Baba
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

4.  Effects of endogenous and exogenous secretin on plasma pancreatic polypeptide concentrations in dogs.

Authors:  F Koizumi; A Ohkawa; T Kawamura; A Ishimori; I Sasaki; J Kameyama
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

5.  Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin secretion in the mouse.

Authors:  B Ahrén; I Lundquist
Journal:  Diabetologia       Date:  1981       Impact factor: 10.122

6.  Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption.

Authors:  R Ebert; H Unger; W Creutzfeldt
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

7.  Rational development of a high-affinity secretin receptor antagonist.

Authors:  Maoqing Dong; Kaleeckal G Harikumar; Sweta R Raval; Juliana E Milburn; Carolyn Clark; Rafael Alcala-Torano; Juan C Mobarec; Christopher A Reynolds; Giovanna Ghirlanda; Arthur Christopoulos; Denise Wootten; Patrick M Sexton; Laurence J Miller
Journal:  Biochem Pharmacol       Date:  2020-03-23       Impact factor: 5.858

8.  Endocrinology of duodenal ulcer.

Authors:  W Creutzfeldt; R Arnold
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

Review 9.  The Role of Incretins on Insulin Function and Glucose Homeostasis.

Authors:  Jens Juul Holst; Lærke Smidt Gasbjerg; Mette Marie Rosenkilde
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

Review 10.  Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes.

Authors:  Jens J Holst; Filip K Knop; Tina Vilsbøll; Thure Krarup; Sten Madsbad
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.